Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Pain Symptom Manage. 2019 Jul 19;58(5):766–773. doi: 10.1016/j.jpainsymman.2019.07.011

Table 3.

Patient-level outcomes after referral to specialty palliative care

Outcomes Liver Disease Cancer P value
AD completed during PC consultation n = 4,065 n = 37,964
 No. (%) 142 (3.5) 1,375(3.6) 0.7
POLST completed during PC consultation n = 4,064 n = 37,955
 No. (%) 526 (12.9) 4,724 (12.4) 0.4
Symptom improvement from 1st to 2nd assessment, No. (%)*
 Pain 228 (64.9) 5,184(68.7) 0.1
 Anxiety 66 (65.3) 1,516(67.9) 0.6
 Nausea 33 (86.8) 1,259 (78.7) 0.2
 Dyspnea 37 (62.7) 935 (65.9) 0.6
In-hospital death n = 4,212 n = 39,073
 No. (%) 1,179(28.0) 6,567(16.8) <0.0001
Discharge location, No. (%) n = 2,946 n = 31,777 <0.0001
 Home 1,432(48.6) 20,557 (64.7)
 Long-term acute care hospital/Extended care facility 609 (20.7) 4,816(15.2)
 Hospital inpatient (PC team signed-off prior to discharge) 456(15.5) 3,246 (10.2)
 Other** 449(15.2) 3,159(9.9)
Services arranged for patients discharged home, No. (%) n= 1,383 n= 19,588
 Hospice 584 (42.2) 7,565 (38.6) 0.008
 Clinic-based PC 41 (3.0) 2,362(12.1) <0.0001
 Home-based PC 65 (4.7) 1,380(7.1) 0.001
 Home health care 321 (23.2) 4,845 (24.8) 0.2
 No services 3,878(19.8) 368 (26.6) <0.0001
*

Includes patients who reported moderate to severe symptoms at the initial PC assessment who reported symptom improvement by at least one level of severity at the second assessment occurring within 72 hours of the initial assessment.

**

“Other” consists of non-hospital inpatient setting, residential care, respite/shelter. Abbreviations: AD, advance directive; PC, palliative care; POLST, physician orders for life-sustaining treatment